J Korean Rheum Assoc.  2010 Mar;17(1):46-50. 10.4078/jkra.2010.17.1.46.

A Case of Dermatomyositis That Developed after Repeated Filler Material Injections for Cosmetic Purposes

• Lee MW
• Youn SY
• Kang SR
• Lee J

• KMID: 2201991
• DOI: http://doi.org/10.4078/jkra.2010.17.1.46

Abstract

Dermatomyositis and polymyositis are uncommon, acquired idiopathic inflammatory myopathies of an unknown etiology. Although there are 9 reported cases in the literature of developing dermatomyositis or polymyositis after collagen dermal injection, it is still controversial whether there is a link between injectable filler materials and autoimmune diseases, and specifically dermatomyositis/polymyositis. We experienced a case of a 40-year-old woman who developed dermatomyositis after repeated injections of multiple filler materials, including collagen for cosmetic purposes, which suggests a temporal relation between the two factors. The benefit-to-risk ratio should be assessed for repeated cosmetic surgical procedures that use filler materials.

Keyword

Dermatomyositis; Cosmetic; Filler injections

MeSH Terms

Adult
Aluminum Hydroxide
Autoimmune Diseases
Carbonates
Collagen
Cosmetics
Dermatomyositis
Female
Humans
Myositis
Polymyositis
Aluminum Hydroxide
Carbonates
Collagen
Cosmetics

Figure

• 

  Fig. 1. Diffuse facial erythema with a heliotrope rash and the patient showed with edematous violet-colored eyelids.

• 

  Fig. 2. Slightly elevated violaceous papules and plaques of thickened, scaly skin over the hand knuckles (Gottron's papules).

Reference

1). Sanchez-Guerrero J., Schur PH., Sergent JS., Liang MH. Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum. 1994. 37:158–68.

2). Kessler DA. The basis of the FDA's decision on breast implants. N Engl J Med. 1992. 326:1713–5.

3). Clark DP., Hanke CW., Swanson NA. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol. 1989. 21:992–8.

4). Cukier J., Beauchamp RA., Spindler JS., Spindler S., Lorenzo C., Trentham DE. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med. 1993. 118:920–8.

5). Koeger AC., Lang T., Alcaix D., Milleron B., Rozenberg S., Chaibi P, et al. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore). 1995. 74:221–37.

6). Oddis CV., Conte CG., Steen VD., Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990. 17:1329–34.

7). Goldstein R., Duvic M., Targoff IN., Reichlin M., McMenemy AM., Reveille JD, et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 1990. 33:1240–8.

8). Magid SK., Kagen LJ. Serologic evidence for acute toxoplasmosis in polymyositis-dermatomyositis. Increased frequency of specific anti-toxoplasma IgM antibodies. Am J Med. 1983. 75:313–20.

9). Christensen ML., Pachman LM., Schneiderman R., Patel DC., Friedman JM. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum. 1986. 29:1365–70.

10). Elson ML. Injectable collagen and autoimmune disease. J Dermatol Surg Oncol. 1993. 19:165–8.

11). Singh G., Fries JF. Autoimmune disease and collagen dermal implants. Ann Intern Med. 1994. 120:524–5.

12). Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol. 1989. 15:301–3.

13). McClelland M., Delustro F. Evaluation of antibody class in response to bovine collagen treatment in patients with urinary incontinence. J Urol. 1996. 155:2068–73.

14). Vanderveen EE., McCoy JP Jr., Schade W., Kapur JJ., Hamilton T., Ragsdale C, et al. The association of HLA and immune responses to bovine collagen implants. Arch Dermatol. 1986. 122:650–4.

15). McCoy JP Jr., Schade WJ., Siegle RJ., Waldinger TP., Vanderveen EE., Swanson NA. Characterization of the humoral immune response to bovine collagen implants. Arch Dermatol. 1985. 121:990–4.